Canada: Court Grants Order Adding Inventor (Intellectual Property Weekly Abstracts Bulletin - Week Of 1 December 2014)

Last Updated: December 5 2014
Most Read Contributor in Canada, September 2016

Edited by Chantal Saunders and Beverley Moore , Adrian Howard and Ryan Steeves

Patent Cases

Court Grants Order Adding Inventor

Dr. Falk Pharma GMBH v. Canada (Commissioner of Patents), 2014 FC 1117

The Applicant, Dr. Falk Pharma GMBH sought an order pursuant to s. 52 of the Patent Act to vary inventorship on a patent. The Application was uncontested and the Respondent did not appear. Affidavit evidence was filed indicating that the omission was inadvertent and due to an absence of knowledge of the different requirements for inventorship under Canadian and German laws. The Court was satisfied with the evidence and granted the order.

Patent Infringement Cases

Pleadings Amendment re s. 53 Allowed – Trial Judge to Determine Materiality of Inventors Names

Gilead Sciences Inc. v. Idenix Pharmaceuticals Inc., 2014 FCA 247

Idenix brought a motion to amend its pleadings. The Prothonotary granted leave to make certain amendments, however denied leave to make certain others relating to s. 53 of the Patent Act. Idenix appealed that decision to a Federal Court Judge, who granted the appeal. Gilead appealed the Judge's decision to the Federal Court of Appeal (FCA).

The FCA denied the appeal. The FCA was not persuaded that the Judge's decision was plainly wrong. The Judge held that the question of whether the disclosure of the names of the inventors of the patent in the petition is a material allegation pursuant to s. 53(1) of the Patent Act is a matter that should be considered by the trial judge.

S. 8 Case not Struck, Despite Prohibition Order Having Issued in Underlying S. 6 Proceeding

Pfizer Canada Inc. v. Teva Canada Limited, 2014 FCA 244

Drug: amlodipine

In this case, the Prothonotary refused to strike a Statement of Claim brought pursuant to s. 8 of the NOC Regulations, and this decision was upheld by the Federal Court Judge (decision here). The FCA upheld the decision.

The underlying facts alleged by Teva are complicated and relate to a number of different patents and proceedings. They are set out in the addendum to the Federal Court decision cited above. However, a prohibition order was granted to Pfizer, against Teva, on appeal of one NOC Proceeding and that patent was later found invalid in an impeachment action brought by Teva.

The FCA held that this was not an appropriate case to resolve any uncertainty in the test with respect to de novo appeals of Prothonotary's decisions. Furthermore, the FCA held that the law relating to s. 8 of the NOC Regulations is still evolving, thus it is not plain and obvious that the claim is doomed to fail.

Trademarks Decisions

Motion for Summary Judgment Granted: Court Awards $15,000 in Damages, $13,000 in Costs

Source Media Group Corp. v. Black Press Group Ltd., 2014 FC 1014

This was a motion for summary judgment claiming relief under the Trademarks Act for the infringement of the Plaintiff's registered trademark NEW HOME LIVING arising from the Defendant's unauthorized use of the trademark NEW HOME LIVING.

The Defendants admitted using the same registered trademark of the Plaintiff, NEW HOME LIVING, up until 2012. In 2012, the Defendants admitted that they stopped using "New Home Living" on its publication, but continued to use a reference to the website until 2014. The Court therefore found that the Defendants have infringed, as admitted, the Plaintiff's trademark during this period, and have passed off their publication, both in print and online form, as being associated or connected to the Plaintiff's trademark. The Court held, however, that there was insufficient evidence before it to support a finding of depreciation of goodwill.

The Plaintiff also argued that the Defendants should not have included settlement discussions in their submissions, as these were subject to a settlement privilege. The Defendants provided a letter from the Plaintiff's counsel which discusses an offer made by the Defendants. The Court held that the Defendants could have limited their comments to the fact that they participated in settlement discussions, and that such disclosure, as made by the Defendants, breached the settlement privilege and should not be encouraged.

The Court held that the Defendants demonstrated a "reproachable attitude" in using the Plaintiff's trademark, which added to the damages of infringement sought. While no evidence of loss and goodwill was submitted, the Plaintiff submitted that an award in the $15,000 to $25,000 range would be adequate. The Court considered applicable case law, and noting the Defendants' "attitude of persistently using the registered trademark", found that damages in the amount of $15,000 were reasonable. In respect of the Defendants' inclusion of documents pertaining to settlement discussions, the Court held that while the actions were inappropriate, the Defendants' conduct did not rise to a level where cost sanctions were necessary. In view of the Defendants' lack of meaningful participation in the proceedings, failure to stop using the trademark reference online, and the fact that "the proceedings should not have gone that far", the Court granted costs in a lump sum amount of $13,000 (plus post-judgment interest at 5%) in favour of the Plaintiff.

Industry News

Industry Canada has announced that the PM(NOC) Regulations will be amended to address the exclusion of certain pharmaceutical patents from Health Canada's Patent Register following recent Federal Court and Federal Court of Appeal decisions relating to patents claiming single medicinal ingredients found in combination drugs. There will be a public consultation once the proposed amendments are pre-published in the Canada Gazette.

The BLG Life Sciences Group has published LIFESIGNS: Life Sciences Legal Trends in Canada, a Report on Intellectual Property, Litigation, Corporate Commercial legal trends and industry developments in Canada.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.